Unlike older treatments, it works as a triple agonist , stimulating GLP-1, GIP, and Glucagon receptors simultaneously
Schedule a consultation with Everest Regenerative Medicine and lets explore whats possible for you, today, and into your future.
In mouse models of DMD, it has been found that IGF1-LR3 and other IGF-1 derivatives are capable of counteracting the negative effects of myostatin to protect muscle cells and prevent apoptosis
10.3389/fbioe.2024.1514890 Front Bioeng Biotechnol
Supplementation with gamma-glutamylcysteine (GGC) could provide the answer as it has been shown to increase cellular GSH above homeostasis effectively [14]
For patients, clinicians, and health systems alike, the arrival of an effective, convenient, and potentially affordable oral GLP-1 agonist represents a major change that could redefine how obesity is treated across the globe